Pfizer joins GSK with FDA greenlight for RSV vaccine

Pending results of a CDC adcomm meeting, Pfizer said it anticipates vaccine supply availability in Q3 2023 ahead of the start of the 2023/24 RSV season this fall.

Related Keywords

United Kingdom ,British ,Annaliesa Anderson ,Pfizer ,Prevention Advisory Committee On Immunization Practices ,Drug Administration ,Centers For Disease ,Products Advisory Committee ,New England Journal ,Related Biological Products Advisory Committee ,Disease Control ,Advisory Committee ,Immunization Practices ,Cut Short ,Famer Earvin ,